Author: By Tamika Matthews
-

Bill’s impact on state Rx affordability board penalizes rare disease patients | OPINION
—
by
Tamika Matthews Senate Bill 060 proposes the Colorado Prescription Drug Affordability Review Board (PDAB) “should have no authority to perform an affordability review of, or establish an upper payment limit for any prescription drug designated for a rare disease or condition as defined by the FDA.” The proposed exemption of “orphan drugs” in this bill…


